Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroblastoma 10Ganglioneuroblastoma 5Glioblastoma 3Brain Neoplasms 3Oligodendroglioma 2Medulloblastoma 2Gliosarcoma 2Glioma 2Astrocytoma 2Rhabdoid Tumor 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 14Etoposide 12Temozolomide 10Carboplatin 9Granulocyte Colony-Stimulating Factor 8Filgrastim 8Vincristine 7etoposide phosphate 6X-Rays 6Thiotepa 6Phantoms, Imaging 6Magnetic Resonance Spectroscopy 6Cisplatin 6Topotecan 5Specimen Handling 5Radiotherapy 5Nuclear Medicine Department, Hospital 5Methotrexate 5fludarabine 4Stem Cell Transplantation 4Peripheral Blood Stem Cell Transplantation 4Mesna 4Melphalan 4Biopsy 4palbociclib 3Sirolimus 3Irinotecan 3Ifosfamide 3Busulfan 3Automobiles 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rhabdoid Tumor × Colony-Stimulating Factors × CNS × Clear all
NCT02444546 2023-04-24

Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors

Mayo Clinic

Phase 1 Completed
6 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioma, Medulloblastoma, Oligodendroglioma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡